GLOBALLUXRX LABORATORIES PRIVATE LIMITED

CIN U21001KA2026FTC215591

Subsidiary of a Foreign CompanyIncorporated 7 February 2026

GLOBALLUXRX LABORATORIES PRIVATE LIMITED is a subsidiary of a foreign company incorporated on 7 February 2026 with the Registrar of Companies, Bangalore. Its CIN is U21001KA2026FTC215591 and it is registered in Bangalore South, Karnataka. Its main business activity is manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc. (NIC 21001). It has an authorised capital of ₹10,00,000 and a paid-up capital of ₹10,00,000. Its directors are PRAVIN EKANATH PATIL and MAKSIMS VLASENKO.

Company details

Name: GLOBALLUXRX LABORATORIES PRIVATE LIMITED
CIN: U21001KA2026FTC215591
Type: Subsidiary of a Foreign Company
Date of incorporation: 7 February 2026
Registrar of Companies: ROC Bangalore
Category: Company limited by shares
Sub-category: Subsidiary of a foreign company
Authorised capital: ₹10,00,000
Paid-up capital: ₹10,00,000
Business activity: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
NIC code: 21001
State: Karnataka
District: Bangalore South

Registered office: No.988,1st Floor, 13th Cross, Bangalore South, Karnataka, 560070

Directors

PRAVIN EKANATH PATILDirector
MAKSIMS VLASENKODirector

First-year compliance calendar

Due dates worked out from the incorporation date. Check the latest MCA notifications for extensions.

Compliance	Due
First board meetingwithin 30 days of incorporation	9 March 2026
Appoint the first auditorby the board, within 30 days	9 March 2026
Issue share certificateswithin 60 days of incorporation	8 April 2026
Commencement of business (INC-20A)within 180 days, after subscribers pay for their shares	6 August 2026
Director KYC (DIR-3 KYC)every year, for each director's DIN	30 September 2026
Financial statements (AOC-4) and annual return (MGT-7A / MGT-7)AGM due by 31 December 2026; AOC-4 within 30 days and MGT-7 within 60 days of it	after the first AGM

What the CIN U21001KA2026FTC215591 means

U — listing: Unlisted
21001 — industry (NIC): Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.
KA — state / ROC code: Karnataka
2026 — year of incorporation: 2026
FTC — ownership: Subsidiary of a Foreign Company
215591 — registration number: Serial number at the ROC

Never miss an ROC deadline for your clients

Finexo's practice management software tracks INC-20A, AOC-4, MGT-7, LLP Form 8 and Form 11 for every client company, assigns the work to your team and reminds clients before the due date.

See Finexo for CA firms

More new companies in Bangalore South

More companies and LLPs

Is this your CIN?

Search another company

Details from Ministry of Corporate Affairs records, last updated 12 October 2026.